Data show that levels of intact FGF23 (iFGF23) increase more with an FCM infusion compared to other IV irons, potentially leading to a cascade of metabolic events including high FGF23, HPP, hypovitaminosis D, hypocalcemia, and secondary hyperparathyroidism [19]. The gene discussed is FGF23; the disease is Hypocalcemia.